HSBC Holdings’s Turning Point Therapeutics, Inc. Common Stock TPTX Stock Holding History

HSBC Holdings’s Portfolio TPTX Stock Details TPTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-185,490	Closed	-$14M	–	3411
2022 Q2	$14M	Buy	+185,490	New	+$8.24M	0.02%	717
2021 Q1	–	Sell	-3,634	Closed	-$449K	–	3258
2020 Q4	$449K	Buy	+3,634	New	+$398K	﹤0.01%	2269
2020 Q3	–	Sell	-3,237	Closed	-$209K	–	2923
2020 Q2	$209K	Buy	+3,237	New	+$187K	﹤0.01%	2341

HSBC Holdings's TPTX Position: Q3 2022 in Review

HSBC Holdings sold out of Turning Point Therapeutics, Inc. Common Stock (TPTX) in Q3 2022, closing a stake of 185,490 shares — an estimated $14M sold.

HSBC Holdings first reported a position in TPTX in Q2 2020 and held it in 3 quarters. The position peaked at $14M in Q2 2022. 0 funds tracked by Wall St. Rank hold TPTX as of Q3 2022.

HSBC Holdings reported no remaining Turning Point Therapeutics, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
HSBC Holdings sold 185,490 Turning Point Therapeutics, Inc. Common Stock shares in Q3 2022, an estimated $14M.
HSBC Holdings first reported a position in Turning Point Therapeutics, Inc. Common Stock in Q2 2020 and held it in 3 quarters.
HSBC Holdings's Turning Point Therapeutics, Inc. Common Stock position peaked at $14M in Q2 2022.
0 funds tracked by Wall St. Rank held Turning Point Therapeutics, Inc. Common Stock as of Q3 2022.

Based on HSBC Holdings's 13F filing for Q3 2022, filed 14 Nov 2022.